PMID: 11921272Mar 29, 2002Paper

21q22 balanced chromosome aberrations in therapy-related hematopoietic disorders: report from an international workshop

Genes, Chromosomes & Cancer
Marilyn L SlovakRosalyn Slater

Abstract

The International Workshop on the relationship between prior therapy and balanced chromosome aberrations in therapy-related myelodysplastic syndromes (t-MDS) and therapy-related acute leukemia (t-AL) identified 79 of 511 (15.5%) patients with balanced 21q22 translocations. Patients were treated for their primary disease, including solid tumors (56%), hematologic malignancy (43%), and juvenile rheumatoid arthritis (single case), by radiation therapy (5 patients), chemotherapy (36 patients), or combined-modality therapy (38 patients). 21q translocations involved common partner chromosomes in 81% of cases: t(8;21) (n = 44; 56%), t(3;21) (n = 16; 20%), and t(16;21) (n = 4; 5%). Translocations involving 15 other partner chromosomes were also documented with involvement of AML1(CBFA2/RUNX1), identifying a total of 23 different 21q22/AML1 translocations. The data analysis was carried out on the basis of five subsets of 21q22 cases, that is, t(8;21) with and without additional aberrations, t(3;21), t(16;21), and other 21q22 translocations. Dysplastic features were present in all 21q22 cases. Therapy-related acute myeloid leukemia (t-AML) at presentation was highest in t(8;21) (82%) and lowest in t(3;21) (37.5%) patients. Cumulative dru...Continue Reading

References

Jul 5, 1992·The New England Journal of Medicine·R E CurtisR N Hoover
Jul 15, 1992·Cancer Genetics and Cytogenetics·J L Carrasco JuanL Hernández Nieto
Dec 1, 1991·Cancer Genetics and Cytogenetics·Z ChenA A Sandberg
Jul 1, 1991·European Journal of Haematology·B JohanssonF Mitelman
Jul 15, 1991·Cancer Genetics and Cytogenetics·M T FerroC San-Román
Jan 1, 1991·Clinical and Laboratory Haematology·P Yates, M N Potter
Dec 12, 1991·The New England Journal of Medicine·C H PuiJ T Sandlund
Oct 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G LongmoreJ H Antin
Jul 15, 1990·Cancer Genetics and Cytogenetics·S D LawlerR Powles
Jul 1, 1989·Cancer Genetics and Cytogenetics·S C RaimondiD L Williams
Jul 20, 1989·The New England Journal of Medicine·C H PuiS B Murphy
Oct 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R B GellerR Saral
Jan 1, 1986·Acta Haematologica·A CaimoA Marmont
Apr 1, 1988·Cancer Genetics and Cytogenetics·P D SherringtonF G Hayhoe
Oct 1, 1986·Cancer Genetics and Cytogenetics·C FonatschW Havers
Feb 1, 1985·Cancer Genetics and Cytogenetics·J R KowalczykA A Sandberg
Jun 1, 1983·Cancer Genetics and Cytogenetics·M SasakiT Tomiyasu
May 1, 1984·Cancer Genetics and Cytogenetics·P C NowellA P Lyss
Nov 1, 1981·Cancer Genetics and Cytogenetics·F MitelmanB Dallapiccola
Dec 1, 1994·Genes, Chromosomes & Cancer·I PanagopoulosF Mitelman
Dec 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R M StoneA S Freedman
Jan 1, 1993·Leukemia & Lymphoma·V Gandhi
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·G NuciforaJ D Rowley
Jul 15, 1993·Cancer Genetics and Cytogenetics·H KobayashiS Furuta
Oct 1, 1995·British Journal of Haematology·L M Secker-WalkerB Bain
Feb 1, 1996·British Journal of Haematology·B JohanssonF Mitelman
Apr 16, 1996·Proceedings of the National Academy of Sciences of the United States of America·Q WangN A Speck
May 1, 1996·American Journal of Hematology·S FujisawaT Okubo
Jun 1, 1996·Cancer Genetics and Cytogenetics·S K GogineniR S Verma
Aug 1, 1996·Cancer Genetics and Cytogenetics·T IzumiY Miura
Apr 1, 1996·Hematology and Cell Therapy·R BergerP Jonveaux

❮ Previous
Next ❯

Citations

May 3, 2005·Nature Reviews. Cancer·Karen BlythJames C Neil
Jun 10, 2008·Current Opinion in Hematology·Jac A NickoloffRobert Hromas
Jan 29, 2013·Molekuliarnaia biologiia·E N MarkovaO L Kantidze
Feb 21, 2008·Acta Haematologica·Christie L Boils, Anwar N Mohamed
Nov 21, 2007·Hematology·Richard A Larson
Apr 2, 2009·Haematologica·Richard A Larson
Dec 23, 2010·Future Oncology·Etienne De BraekeleerMarc De Braekeleer
Mar 8, 2011·Medical Oncology·Antonio Roberto Lucena-AraujoEduardo Magalhães Rego
Mar 2, 2010·Women's Health·Francesco Lo-CocoSafaa M Ramadan
Oct 29, 2014·Expert Review of Hematology·Nicolas DuployezClaude Preudhomme
Nov 19, 2011·Hematology/oncology Clinics of North America·David Grimwade, Krzysztof Mrózek
Feb 19, 2011·Leukemia Research·Eliane Maria Soares-VenturaMaria Tereza Cartaxo Muniz
Dec 2, 2008·Best Practice & Research. Clinical Haematology·Jasmine C WongKevin Shannon
Aug 12, 2008·Seminars in Oncology·Lucy A Godley, Richard A Larson
May 30, 2007·European Journal of Haematology·Shizuka ImagamaTomoki Naoe
Aug 9, 2006·DNA Repair·Yanming Zhang, Janet D Rowley
Jul 22, 2006·DNA Repair·Carolyn A FelixNeil Osheroff
Jun 2, 2006·Cancer Genetics and Cytogenetics·Attaphol PawarodeMaria R Baer
Apr 18, 2006·Cancer Genetics and Cytogenetics·Eric JeandidierUNKNOWN Groupe Français de Cytogénétique Hématologique (GFCH)
Nov 1, 2005·Trends in Genetics : TIG·Peter D Aplan
Aug 5, 2014·American Journal of Hematology·Melhem SolhCelalettin Ustun
Jul 6, 2015·Current Treatment Options in Oncology·Simon B Zeichner, Martha L Arellano
Oct 4, 2012·Leukemia Research·Ibrahim Aldoss, Vinod Pullarkat
Jun 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wolfgang KernClaudia Schoch
Aug 19, 2009·American Journal of Clinical Pathology·Magdalena Czader, Attilio Orazi
Mar 24, 2018·Molecular Biology Reports·Ameer HamzaDaniel Snower
Apr 1, 2019·Best Practice & Research. Clinical Haematology·Prajwal C Boddu, Amer M Zeidan
Jan 19, 2020·Clinical Lymphoma, Myeloma & Leukemia·Prajwal DhakalVijaya Raj Bhatt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.